Assam Reporter

Celiac Disease (CD) Market Analysis, Market Size, Epidemiology, Leading Companies And Competitive Analysis By DelveInsight

 Breaking News
  • No posts were found

Celiac Disease (CD) Market Analysis, Market Size, Epidemiology, Leading Companies And Competitive Analysis By DelveInsight

June 03
23:56 2021
Celiac Disease (CD) Market Analysis, Market Size, Epidemiology, Leading Companies And Competitive Analysis By DelveInsight

DelveInsight Business Research LLP
DelveInsight’s “Celiac Disease (CD)–Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Celiac Disease (CD), historical and forecasted epidemiology as well as the Celiac Disease (CD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

DelveInsight has launched a new report on “Celiac Disease (CD)-Market Insights, Epidemiology, and Market Forecast-2030”.

DelveInsight’s “Celiac Disease (CD)–Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Celiac Disease (CD), historical and forecasted epidemiology as well as the Celiac Disease (CD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some of the key facts of the Report:

 

  1. The total prevalent population of CD in the 7 major markets was found to be 6,334,993 in 2017. The total 7MM diagnosed prevalent cases of CD in 2017 were 1,303,459 out of which the highest diagnosed prevalent cases of this disease were seen in the United States, which was 661,244. 

  2. DelveInsight has found 238,048 and 423,196 cases of males and females in the United States, in 2017. 

  3. It was found that in the United States the number of cases of Classical, Non-classical and Sub-clinical was 178,536, 343,847 and 138,861 respectively, in 2017. 

  4. In the EU5 countries, the total prevalent population of CD was found to be maximum in Germany with 738,357 cases, followed by the United Kingdom with 650,676 cases in 2017. 

  5. While, the least number of cases were found in Spain, i.e., 421,326 in 2017.

  6. In Japan, the prevalence of CD was found to be 65,148 in 2017.

Key benefits of the report:

1.The Celiac Disease (CD) market report covers a descriptive overview and comprehensive insight of the Celiac Disease (CD) Epidemiology and Celiac Disease (CD) market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)

2.The Celiac Disease (CD) market report provides insights into the current and emerging therapies.

3.Celiac Disease (CD) market report provides a global historical and forecasted market covering drug outreach in 7MM.

4.The Celiac Disease (CD) market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Celiac Disease (CD) market.

Request for sample pages: https://www.delveinsight.com/sample-request/celiac-disease-cd-market

Celiac Disease (CD): Overview

Celiac disease (CD) is a common disorder that is estimated to affect about one percent of the population. It is a condition in which the absorptive surface of the small intestine is damaged by a substance called gluten. Gluten is a group of proteins present in wheat, rye and barley and their cross bred grains.

The key players involved in the Celiac Disease (CD) market:

 

  1. ImmunoGenX

  2. 9 Meters Biopharma

  3. Cour Pharmaceutical/ Takeda

  4. Provention Bio

  5. Falk Pharma and Zedira

  6. Precigen ActoBio

  7. Takeda

The launch of the emerging therapies is expected to significantly impact the  Celiac Disease (CD) treatment scenario in the upcoming years:-

Drug covered

  1. Latiglutenase (IMGX003)

  2. Larazotide Acetate

  3. CNP-101/ TAK-101

  4. PRV-015 (AMG 714)

  5. ZED1227

  6. AG017

  7. TAK-062

Request a free sample report @https://www.delveinsight.com/sample-request/celiac-disease-cd-market

Table of Contents

1. Report Introduction

2. Executive Summary

3. SWOT analysis

4. Celiac Disease (CD) Patient Share (%) Overview at a Glance

5. Celiac Disease (CD) Market Overview at a Glance

6. Celiac Disease (CD) Disease Background and Overview

7. Celiac Disease (CD) Epidemiology and Patient Population

8. Country-Specific Patient Population of Celiac Disease (CD) 

9. Celiac Disease (CD) Current Treatment and Medical Practices

10. Unmet Needs

11. Celiac Disease (CD) Emerging Therapies

12. Celiac Disease (CD) Market Outlook

13. Country-Wise Celiac Disease (CD) Market Analysis (2017–2030)

14. Market Access and Reimbursement of Therapies

15. Market drivers

16. Market barriers

17. Appendix

18. Celiac Disease (CD) Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

Related Report:

Celiac Disease (CD)-Epidemiology Forecast to 2030

DelveInsight’s ‘Celiac Disease (CD)-Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Celiac Disease (CD) {;l epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Related Articles